Astec LifeSciences Limited announced audited standalone earnings results for fourth quarter and full year ended May 31, 2018. For the quarter, the company reported total income from operations was INR 1,301.402 million against INR 912.913 million a year ago. Profit before exceptional items & tax was INR 266.094 million against INR 101.823 million a year ago. Profit before tax was INR 266.094 million against INR 41.505 million a year ago. Profit for the period was INR 170.979 million against INR 34.922 million a year ago. Diluted per equity share was INR 8.74 against basic and diluted per equity share of INR 1.79 a year ago. EBITDA was INR 329 million against INR 173 million a year ago. For the full year, the company reported total income from operations was INR 3,789.514 million against INR 3,156.028 million a year ago. Profit before exceptional items & tax was INR 515.257 million against INR 392.293 million a year ago. Profit before tax was INR 556.778 million against INR 286.272 million a year ago. Profit for the period was INR 349.708 million against INR 190.942 million a year ago. Diluted per equity share was INR 17.88 against INR 9.77 a year ago. EBITDA was INR 768 million against INR 651 million a year ago.